pI: 6.9497 |
Length (AA): 2498 |
MW (Da): 285702 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 9 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
388 | 573 | 2fnj (A) | 47 | 247 | 17.00 | 0 | 0.28 | 0.18 | -0.02 |
607 | 664 | 2hc8 (A) | 240 | 294 | 29.00 | 0.3 | 0.24 | 0.219119 | 0.17 |
1065 | 1144 | 1jhn (A) | 276 | 350 | 35.00 | 0.15 | 0.03 | 0.244726 | 0.11 |
1276 | 1417 | 2yyo (A) | 17 | 162 | 31.00 | 0.000000022 | 1 | 0.453545 | -0.46 |
1283 | 1415 | 3toj (A) | 310 | 485 | 22.00 | 0.00000003 | 0.96 | 0.345943 | -0.4 |
1514 | 1571 | 1w9r (A) | 62 | 119 | 38.00 | 0.37 | 0.07 | 0.515919 | -2.55 |
1528 | 1574 | 1jbj (A) | 76 | 122 | 40.00 | 0.37 | 0.01 | 0.497515 | -0.87 |
2212 | 2432 | 4tql (A) | 9 | 228 | 14.00 | 0.0003 | 0.04 | 0.230371 | -0.59 |
2255 | 2436 | 4uos (A) | 3 | 184 | 8.00 | 0.023 | 0 | 0.218758 | -1.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_128341)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G09340 | SPla/RYanodine receptor (SPRY) domain-containing protein |
Arabidopsis thaliana | AT1G35470 | RanBPM-like protein |
Babesia bovis | BBOV_IV010250 | PRY domain containing protein |
Brugia malayi | Bm1_02375 | hypothetical protein |
Brugia malayi | Bm1_02380 | SPRY domain containing protein |
Caenorhabditis elegans | CELE_Y54E5A.7 | Protein Y54E5A.7, isoform D |
Dictyostelium discoideum | DDB_G0292780 | hypothetical protein |
Drosophila melanogaster | Dmel_CG42236 | Ran-binding protein M |
Echinococcus granulosus | EgrG_000657210 | ran binding protein 9 |
Echinococcus granulosus | EgrG_000467400 | ran binding protein 9 |
Entamoeba histolytica | EHI_091560 | hypothetical protein, conserved domain containing |
Echinococcus multilocularis | EmuJ_000467400 | ran binding protein 9 |
Echinococcus multilocularis | EmuJ_000657210 | ran binding protein 9 |
Homo sapiens | ENSG00000141084 | RAN binding protein 10 |
Homo sapiens | ENSG00000010017 | RAN binding protein 9 |
Loa Loa (eye worm) | LOAG_03825 | hypothetical protein |
Mus musculus | ENSMUSG00000037415 | RAN binding protein 10 |
Mus musculus | ENSMUSG00000038546 | RAN binding protein 9 |
Neospora caninum | NCLIV_000110 | Arabinogalactan protein, related |
Plasmodium berghei | PBANKA_1212700 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1014300 | conserved protein, unknown function |
Plasmodium knowlesi | PKNH_0814400 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_094930 | hypothetical protein, conserved |
Plasmodium yoelii | PY04751 | arabinogalactan protein |
Plasmodium yoelii | PY04750 | SPRY domain, putative |
Schistosoma japonicum | Sjp_0029280 | IPR006595,CTLH, C-terminal to LisH motif;IPR013144,CT11-RanBPM,domain-containing |
Schistosoma japonicum | Sjp_0311550 | similar to Uncharacterized protein C1259.12c, putative |
Schistosoma japonicum | Sjp_0117750 | hypothetical protein |
Schistosoma mansoni | Smp_161080 | ran binding protein 9-related |
Schmidtea mediterranea | mk4.002346.03 | |
Toxoplasma gondii | TGME49_293060 | SPRY domain-containing protein |
Theileria parva | TP01_0782 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_293060 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.